Shanghai Chemowanbang Biopharma

Shanghai Chemo Wanbang Biopharma is a specialized biopharmaceutical subsidiary of Fosun Pharma, focused on the production of high-quality recombinant protein therapeutics. The company's flagship product is Yi Bao (recombinant human erythropoietin), a leading treatment in China for anemia resulting from chronic renal failure and chemotherapy. In addition to erythropoietin, the company manufactures insulin products and other biologics, leveraging its advanced GMP-certified facilities in Shanghai. As a key component of Fosun Pharma's biologics division, it plays a significant role in both domestic supply and international export of essential biopharmaceutical products.